NCT01529281

Brief Summary

It is well documented that exercise-induced muscle damage (EIMD) decreases muscle function and causes severe soreness and discomfort. Branched-chain amino acid (BCAA) supplementation has been shown to increase protein synthesis and decrease muscle protein breakdown, however, the effects of BCAAs on recovery from EIMD are unknown. Thus, the aim of this study was to examine the effects of a BCAA supplement on markers of muscle damage.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2011

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 2, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 8, 2012

Completed
Last Updated

February 8, 2012

Status Verified

February 1, 2012

Enrollment Period

3 months

First QC Date

February 2, 2012

Last Update Submit

February 6, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maximal voluntary contraction

    Isometric MVC of the participants' dominant knee extensors was assessed using a strain gauge. MVCs were performed for 3 s with a 60 s rest between each repetition.

    pre exercise, 24 h, 48 h, 72 h, 96 h post-exercise

Secondary Outcomes (4)

  • Limb girths

    pre-exercise, 24h, 48h, 72h, 96h

  • Vertical jump

    pre-exercise, 24h, 48h, 72h, 96h

  • Creatine kinase

    pre-exercise, 24h, 48h, 72h, 96h

  • Muscle soreness

    pre-exercise, 24h, 48h, 72h, 96h

Study Arms (2)

BCAA

EXPERIMENTAL

Branched chain amino acid

Dietary Supplement: Branch Chain Amino Acid (BCAA)

Asparmate

PLACEBO COMPARATOR

Placebo control containing no protein or carbohydrate

Dietary Supplement: Placebo - asparmate

Interventions

Supplementation lasted for a total of 12 days; this was based on previous research showing a positive with BCAA supplementation on markers of muscle damage. Participants ingested 10 g, twice per day (morning and evening) of BCAA . The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively). The BCAA was in powder form where each serving was mixed with \~300 ml of water.

BCAA
Placebo - asparmateDIETARY_SUPPLEMENT

Supplementation lasted for a total of 12 days. Participants ingested an equivalent looking volume to 10 g of BCAA, twice per day (morning and evening) of placebo (aspartame based artificial sweetener). The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively). The artificial sweetener was in powder form where each serving was mixed with \~300 ml of water.

Asparmate

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- Resistance trained males

You may not qualify if:

  • \- Muscular skeletal disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Howatson G, Hoad M, Goodall S, Tallent J, Bell PG, French DN. Exercise-induced muscle damage is reduced in resistance-trained males by branched chain amino acids: a randomized, double-blind, placebo controlled study. J Int Soc Sports Nutr. 2012 Jul 12;9:20. doi: 10.1186/1550-2783-9-20. eCollection 2012.

MeSH Terms

Interventions

Amino Acids

Intervention Hierarchy (Ancestors)

Amino Acids, Peptides, and Proteins

Study Officials

  • Glyn Howatson, PhD

    Northumbria University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2012

First Posted

February 8, 2012

Study Start

June 1, 2011

Primary Completion

September 1, 2011

Study Completion

September 1, 2011

Last Updated

February 8, 2012

Record last verified: 2012-02